Shiseido News

My post on Shiseido’s Phase 3 clinical trials for hair loss has the latest updates as of 2024. The company’s technology entails culturing dermal sheath cup cells (DSCs).

Also check out the Japanese company’s very popular Adensoine based Shiseido Adenovital shampoo.

Shiseido Logo

Shiseido Cell Processing Facility
Shiseido’s Updated World Map. Kobe Cell Processing and Expansion Facility.

Shiseido Hair Regeneration

The company has two pages on its site in related to hair regeneration:

  1. Hair regenerative medicine.
  2. New research areas.

Shiseido collaborates with University Hospitals (Japan) on a clinical study in regards to hair regenerative medicine technology in Japan. The company also used Replicel (Canada)’s technology via a licensing agreement pertaining to the Asia/Pacific region.

This technology entails culturing dermal sheath cup cells (DSCs). These represent the source of hair dermal papilla cells, which play a critical role in the growth of scalp hair.

For a patient with hair loss (male of female pattern baldness), these DSCs are implanted via injection into the balding scalp skin. The cells then rejuvenate damaged hair follicles and promote the growth of healthy hair.

Make sure to also read my 2014 post on Shiseido’s at-the-time new research facility in the Kobe Biomedical Innovation Cluster (KBIC). This location is also home to RIKEN’s hair research center.

Leave a Reply

Your email address will not be published. Required fields are marked *